News
Mems-ID welcomes new members to the Board of Directors and appoints new Chairman Mems-ID is pleased to announce the appointment of Iain Kirkwood to the Board of Directors, effective 1 November, 2007. Iain has been associated with the company, including as a shareholder, since May 2005 and has chaired the company’s Commercial Advisory Panel (CAP) since March 2007. Iain is a Chartered Accountant with over 25 years financial and operational experience across a range of industries, having held a range of senior positions with major public companies in the USA, UK and Australia. These have included FH Faulding, Santos Limited and Pilkington. Iain was the Managing Director and CEO of EpiTan Limited (now Clinuvel Limited - CUV) until November 2005. Iain is a Non-Executive Director of Medical Developments International Ltd (MVP) and Vision Group Holdings Ltd (VGH), both listed on the Australian Stock Exchange (ASX). Iain also chairs the Audit and Risk Committee of each of these companies. Iain has a MA Hons from Oxford University, is a Fellow of CPA Australia, a Fellow of The Finance and Treasury Association, an Associate of the Institute of Chartered Accountants of Australia, as well as a Member of the Australian Institute of Company Directors. Dr Mike Murray, Mems-ID’s founding chairman, has handed over the Chairman’s role to Mr Kirkwood. Dr Murray will remain as a non-executive director of the company and take up a role on the Technical Advisory Panel (TAP). In addition, Fraser Clayton, Mems-ID’s Chief Executive Officer (CEO), has been appointed to the board and will take up the role of Managing Director (MD), effective immediately. The re-composition of the Board of Directors has been precipitated by the Board’s recent decision to prepare the company for listing on the ASX in 2008, as well as to oversee the next phase of the company’s evolution towards the commercialisation of the Mems-ID™ product.
| |||
 |
|||
|